Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Tapimio
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tapimio 100mg modified-release capsules
0407020AGBGABAK
|
Tapimio | Tapentadol | Central Nervous System | No data available |
|
Tapimio 150mg modified-release capsules
0407020AGBGACAL
|
Tapimio | Tapentadol | Central Nervous System | No data available |
|
Tapimio 200mg modified-release capsules
0407020AGBGADAM
|
Tapimio | Tapentadol | Central Nervous System | No data available |
|
Tapimio 250mg modified-release capsules
0407020AGBGAEAN
|
Tapimio | Tapentadol | Central Nervous System | No data available |
|
Tapimio 50mg modified-release capsules
0407020AGBGAAAJ
|
Tapimio | Tapentadol | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.